Heng-Cheng Hsu

27PUBLICATIONS
101CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersObstetrics and gynaecologyMedical anthropologyComparative language studies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jul 01, 2026
Complete Response to Immune Checkpoint Inhibitor-Based Combination Therapy in PD-L1-High, Tumor Mutational Burden-Low Ovarian Sarcomatoid Squamous Cell Carcinoma.

|Dec 19, 2025
Association of homologous recombination repair gene mutation with clinical prognosis in histological subtypes of epithelial ovarian cancer patients.

Yen-Han Wang, Heng-Cheng Hsu, Po-Han Lin

|Jul 23, 2025
Long-term outcomes of fertility-sparing treatment in endometrial carcinoma and endometrial intraepithelial neoplasia: Recurrence risk factors over a 9-year follow-up.

Ya-Ting Hsu, Heng-Cheng Hsu, Chia-Yi Lee

|Aug 20, 2024
Isolated tumor cells in low-risk endometrial cancer: are we ready for treatment decisions in 'isolation'?

Heng-Cheng Hsu, Pedro T Ramirez

|Aug 08, 2024
Cervical cancer: a new era.

Giuseppe Caruso, Matthew K Wagar, Heng-Cheng Hsu

|Mar 08, 2024
The 8th Biennial Meeting of the Asian Society of Gynecologic Oncology, December 1st to 3rd, 2023.

Heng-Cheng Hsu, Jae-Weon Kim, Jeong-Yeol Park

Pageof 5

Frequent Collaborators

6 joint publications

Yi-Jou Tai

6 joint publications

Ying-Cheng Chiang

5 joint publications

Pedro T Ramirez

4 joint publications

Wen-Fang Cheng